Pharmaceuticals, Biotechnology and Life Sciences
DEER PARK, Ill., March 07, 2023 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc. (Nasdaq: ETON), an innovative pharmaceutical company focused on…
Underwriters’ full exercise of option brings gross proceeds to $345.0 millionREDWOOD CITY, Calif., March 07, 2023 (GLOBE NEWSWIRE) — Revolution…
FeraMAX Pd Maintenance 45 FeraMAX Pd Maintenance 45 MISSISSAUGA, Ontario, March 07, 2023 (GLOBE NEWSWIRE) — On the eve of…
FRTX-02 was generally safe and well tolerated within the potential therapeutic dose range, meeting the study’s primary objectives Plasma concentrations…
SAN DIEGO, March 07, 2023 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics designed…
TORONTO, March 06, 2023 (GLOBE NEWSWIRE) — Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQB: MVMDF)…
Company preparing to initiate Phase 3 clinical trials of TTP399, an adjunctive therapy to insulin, for the treatment of Type…
NEWS RELEASE – REGULATED INFORMATION MARCH 6, 2023, 5:30 pm ET/ 23:30 CET IRVINE, CA, and HERSTAL, BELGIUM – March 6,…
NEW YORK, March 06, 2023 (GLOBE NEWSWIRE) — Cellectis S.A. (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology company…
First patient dosed in pivotal Phase 3 FIREFLY-2/LOGGIC trial evaluating tovorafenib (DAY101) as a frontline therapy for patients newly diagnosed…